These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11306219)

  • 1. Treating substance abuse in schizophrenia. An initial report.
    Bennett ME; Bellack AS; Gearon JS
    J Subst Abuse Treat; 2001 Mar; 20(2):163-75. PubMed ID: 11306219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of drug dependence].
    Backmund M
    Internist (Berl); 1999 Jun; 40(6):597-600. PubMed ID: 10420311
    [No Abstract]   [Full Text] [Related]  

  • 3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What happens when contingency management treatment ends? A tale of two clients.
    Petry NM; Kelley L; Brennan M; Sierra S
    Am J Addict; 2008; 17(3):241-4. PubMed ID: 18464002
    [No Abstract]   [Full Text] [Related]  

  • 7. Different components of opioid-substitution treatment predict outcomes of patients with and without a parent with substance-use problems.
    Trafton JA; Tracy SW; Oliva EM; Humphreys K
    J Stud Alcohol Drugs; 2007 Mar; 68(2):165-72. PubMed ID: 17286334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating effect of alcohol use on cocaine use.
    Magura S; Rosenblum A
    Addict Behav; 2000; 25(1):117-22. PubMed ID: 10708326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.
    Katz EC; Chutuape MA; Jones HE; Stitzer ML
    Exp Clin Psychopharmacol; 2002 May; 10(2):136-43. PubMed ID: 12022799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivational interviewing and treatment retention among drug user patients: a pilot study.
    Secades-Villa R; Fernánde-Hermida JR; Arnáez-Montaraz C
    Subst Use Misuse; 2004 Jul; 39(9):1369-78. PubMed ID: 15462235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
    Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
    Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity of schizophrenia and substance abuse: implications for treatment.
    Mueser KT; Bellack AS; Blanchard JJ
    J Consult Clin Psychol; 1992 Dec; 60(6):845-56. PubMed ID: 1460148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
    Levin FR; Evans SM; Coomaraswammy S; Collins ED; Regent N; Kleber HD
    Am J Drug Alcohol Abuse; 1998 Aug; 24(3):343-60. PubMed ID: 9741939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving treatment engagement and outcomes for cocaine-using methadone patients.
    Villano CL; Rosenblum A; Magura S; Fong C
    Am J Drug Alcohol Abuse; 2002; 28(2):213-30. PubMed ID: 12014813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders.
    Carrà G; Scioli R; Monti MC; Marinoni A
    Eur Addict Res; 2006; 12(2):96-101. PubMed ID: 16543745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of substance-abusing persons with schizophrenia: the paradox of the dually diagnosed.
    Penk WE; Flannery RB; Irvin E; Geller J; Fisher W; Hanson MA
    J Addict Dis; 2000; 19(1):23-30. PubMed ID: 10772600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crack cocaine and schizophrenia as risk factors for PPD reactivity in the dually diagnosed.
    Taubes T; Galanter M; Dermatis H; Westreich L
    J Addict Dis; 1998; 17(3):63-74. PubMed ID: 9789160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.